MicroRNAs and neurodegeneration: Role and impact

Trends in Cell Biology

Volumn 23, Issue 1, 2013, Pages 30-36

  Abe, Masashi ^a   Bonini, Nancy M ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Aging; Dicer; MicroRNA; MiRNA biogenesis; Neurodegenerative disease; Small RNAs

Indexed keywords

DICER; MICRORNA; MICRORNA 34; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG;

BIOGENESIS; CELL STRUCTURE; DOWN REGULATION; DROSOPHILA; FAMILIAL DISEASE; GENE SILENCING; HIPPOCAMPUS; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SCHWANN CELL; TEMPORAL LOBE EPILEPSY;

AGING; BRAIN; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MICRORNAS; NEURODEGENERATIVE DISEASES;

EID: 84871609151     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2012.08.013     Document Type: Review

References (100)

1. Orr H.T., Zoghbi H.Y. Trinucleotide repeat disorders. Annu. Rev. Neurosci. 2007, 30:575-621.
2. Ballard C., et al. Alzheimer's disease. Lancet 2011, 377:1019-1031.
3. O'Brien R.J., Wong P.C. Amyloid precursor protein processing and Alzheimer's disease. Annu. Rev. Neurosci. 2011, 34:185-204.
4. Ferraiuolo L., et al. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2011, 7:616-630.
5. Coelho M., Ferreira J.J. Late-stage Parkinson disease. Nat. Rev. Neurol. 2012, 8:435-442.
6. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
7. Czech B., Hannon G.J. Small RNA sorting: matchmaking for Argonautes. Nat. Rev. Genet. 2011, 12:19-31.
8. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
9. Krol J., et al. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010, 11:597-610.
10. Lagos-Quintana M., et al. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 2002, 12:735-739.
11. Bak M., et al. MicroRNA expression in the adult mouse central nervous system. RNA 2008, 14:432-444.
12. Landgraf P., et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414.
13. Berezikov E., et al. Many novel mammalian microRNA candidates identified by extensive cloning and RAKE analysis. Genome Res. 2006, 16:1289-1298.
14. Kapsimali M., et al. MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system. Genome Biol. 2007, 8:R173.
15. Sanuki R., et al. miR-124a is required for hippocampal axogenesis and retinal cone survival through Lhx2 suppression. Nat. Neurosci. 2011, 14:1125-1134.
16. Cao X., et al. A functional study of miR-124 in the developing neural tube. Genes Dev. 2007, 21:531-536.
17. Visvanathan J., et al. The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. Genes Dev. 2007, 21:744-749.
18. Bernstein E., et al. Dicer is essential for mouse development. Nat. Genet. 2003, 35:215-217.
19. Giraldez A.J., et al. MicroRNAs regulate brain morphogenesis in zebrafish. Science 2005, 308:833-838.
20. Schaefer A., et al. Cerebellar neurodegeneration in the absence of microRNAs. J. Exp. Med. 2007, 204:1553-1558.
21. Damiani D., et al. Dicer inactivation leads to progressive functional and structural degeneration of the mouse retina. J. Neurosci. 2008, 28:4878-4887.
22. Davis T.H., et al. Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J. Neurosci. 2008, 28:4322-4330.
23. Choi P.S., et al. Members of the miRNA-200 family regulate olfactory neurogenesis. Neuron 2008, 57:41-55.
24. Kim J., et al. A MicroRNA feedback circuit in midbrain dopamine neurons. Science 2007, 317:1220-1224.
25. McLoughlin H.S., et al. Dicer is required for proliferation, viability, migration and differentiation in corticoneurogenesis. Neuroscience 2012, 223:285-295.
26. Haramati S., et al. miRNA malfunction causes spinal motor neuron disease. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:13111-13116.
27. Tao J., et al. Deletion of astroglial Dicer causes non-cell-autonomous neuronal dysfunction and degeneration. J. Neurosci. 2011, 31:8306-8319.
28. Shin D., et al. Dicer ablation in oligodendrocytes provokes neuronal impairment in mice. Ann. Neurol. 2009, 66:843-857.
29. Pereira J.A., et al. Dicer in Schwann cells is required for myelination and axonal integrity. J. Neurosci. 2010, 30:6763-6775.
30. McKiernan R.C., et al. Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis. PLoS ONE 2012, 7:e35921.
31. Gehrke S., et al. Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature 2010, 466:637-641.
32. Bilen J., et al. MicroRNA pathways modulate polyglutamine-induced neurodegeneration. Mol. Cell 2006, 24:157-163.
33. Liu N., et al. The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature 2012, 482:519-523.
34. Stark K.L., et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 2008, 40:751-760.
35. Fenelon K., et al. Deficiency of Dgcr8, a gene disrupted by the 22q11.2 microdeletion, results in altered short-term plasticity in the prefrontal cortex. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:4447-4452.
36. Schofield C.M., et al. Monoallelic deletion of the microRNA biogenesis gene Dgcr8 produces deficits in the development of excitatory synaptic transmission in the prefrontal cortex. Neural Dev. 2011, 6:11.
37. Knuckles P., et al. Drosha regulates neurogenesis by controlling Neurogenin 2 expression independent of microRNAs. Nat. Neurosci. 2012, 15:962-969.
38. Macias S., et al. DGCR8 HITS-CLIP reveals novel functions for the Microprocessor. Nat. Struct. Mol. Biol. 2012, 19:760-766.
39. Delay C., et al. MicroRNAs in Alzheimer's disease. Neurobiol. Dis. 2012, 46:285-290.
40. Mouradian M.M. MicroRNAs in Parkinson's disease. Neurobiol. Dis. 2012, 46:279-284.
41. Gascon E., Gao F.B. Cause or effect: misregulation of microRNA pathways in neurodegeneration. Front. Neurosci. 2012, 6:48.
42. Hebert S.S., et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:6415-6420.
43. Wang W.X., et al. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J. Neurosci. 2008, 28:1213-1223.
44. Fang M., et al. The miR-124 regulates the expression of BACE1/beta-secretase correlated with cell death in Alzheimer's disease. Toxicol. Lett. 2012, 209:94-105.
45. Zhu H.C., et al. MicroRNA-195 downregulates Alzheimer's disease amyloid-beta production by targeting BACE1. Brain Res. Bull. 2012, 88:596-601.
46. Wang W.X., et al. Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol. 2011, 121:193-205.
47. Hebert S.S., et al. Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum. Mol. Genet. 2010, 19:3959-3969.
48. Long J.M., Lahiri D.K. Current drug targets for modulating Alzheimer's amyloid precursor protein: role of specific micro-RNA species. Curr. Med. Chem. 2011, 18:3314-3321.
49. Long J.M., et al. MicroRNA-153 physiologically inhibits expression of amyloid-beta precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients. J. Biol. Chem. 2012, 287:31298-31310.
50. Liang C., et al. MicroRNA-153 negatively regulates the expression of amyloid precursor protein and amyloid precursor-like protein 2. Brain Res. 2012, 1455:103-113.
51. Buratti E., et al. Nuclear factor TDP-43 can affect selected microRNA levels. FEBS J. 2010, 277:2268-2281.
52. Williams A.H., et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 2009, 326:1549-1554.
53. Karres J.S., et al. The conserved microRNA miR-8 tunes atrophin levels to prevent neurodegeneration in Drosophila. Cell 2007, 131:136-145.
54. Yanagisawa H., et al. Protein binding of a DRPLA family through arginine-glutamic acid dipeptide repeats is enhanced by extended polyglutamine. Hum. Mol. Genet. 2000, 9:1433-1442.
55. Fuchs J., et al. The transcription factor PITX3 is associated with sporadic Parkinson's disease. Neurobiol. Aging 2009, 30:731-738.
56. Le W., et al. Transcription factor PITX3 gene in Parkinson's disease. Neurobiol. Aging 2011, 32:750-753.
57. Gui Y., et al. A novel synonymous SNP in PITX3 is associated with Parkinson's disease in Chinese population. Swiss Med. Wkly. 2012, 142:w13521.
58. de Mena L., et al. Analysis of the Micro-RNA-133 and PITX3 genes in Parkinson's disease. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2010, 153B:1234-1239.
59. Cai Y., et al. Genetic variants of the PITX3 gene are not associated with late-onset sporadic Parkinson's disease in a Chinese population. Neurosci. Lett. 2011, 498:124-126.
60. Cai Y., et al. PITX3 polymorphism is not associated with Parkinson's disease in a Chinese population. Neurosci. Lett. 2011, 505:260-262.
61. Heyer M.P., et al. Normal midbrain dopaminergic neuron development and function in miR-133b mutant mice. J. Neurosci. 2012, 32:10887-10894.
62. Wong M.Y., et al. microRNA-34 family and treatment of cancers with mutant or wild-type p53 (Review). Int. J. Oncol. 2011, 38:1189-1195.
63. He X., et al. The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res. 2007, 67:11099-11101.
64. Khanna A., et al. Gain of survival signaling by down-regulation of three key miRNAs in brain of calorie-restricted mice. Aging (Albany N. Y.) 2011, 3:223-236.
65. Li X., et al. Circulatory miR34a as an RNAbased, noninvasive biomarker for brain aging. Aging (Albany N. Y.) 2011, 3:985-1002.
66. Wang X., et al. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res. Bull. 2009, 80:268-273.
67. Zovoilis A., et al. microRNA-34c is a novel target to treat dementias. EMBO J. 2011, 30:4299-4308.
68. Rohn T.T., et al. Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2. J. Neurosci. 2008, 28:3051-3059.
69. Gaughwin P.M., et al. Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease. Hum. Mol. Genet. 2011, 20:2225-2237.
70. Minones-Moyano E., et al. MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Hum. Mol. Genet. 2011, 20:3067-3078.
71. Hughes K.A., Reynolds R.M. Evolutionary and mechanistic theories of aging. Annu. Rev. Entomol. 2005, 50:421-445.
72. Curran S.P., Ruvkun G. Lifespan regulation by evolutionarily conserved genes essential for viability. PLoS Genet. 2007, 3:e56.
73. Yang J., et al. MiR-34 modulates Caenorhabditis elegans lifespan via repressing the autophagy gene atg9. Age (Dordr.) 2011, 10.1007/s11357-011-9324-3.
74. Savas J.N., et al. Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:10820-10825.
75. Lee S.T., et al. Altered microRNA regulation in Huntington's disease models. Exp. Neurol. 2011, 227:172-179.
76. Johnson R., et al. REST regulates distinct transcriptional networks in embryonic and neural stem cells. PLoS Biol. 2008, 6:e256.
77. Zuccato C., et al. Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease. J. Neurosci. 2007, 27:6972-6983.
78. Conaco C., et al. Reciprocal actions of REST and a microRNA promote neuronal identity. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:2422-2427.
79. Wu J., Xie X. Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression. Genome Biol. 2006, 7:R85.
80. Johnson R., et al. A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiol. Dis. 2008, 29:438-445.
81. Johnson R., Buckley N.J. Gene dysregulation in Huntington's disease: REST, microRNAs and beyond. Neuromolecular Med. 2009, 11:183-199.
82. Packer A.N., et al. The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. J. Neurosci. 2008, 28:14341-14346.
83. Marti E., et al. A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing. Nucleic Acids Res. 2010, 38:7219-7235.
84. Gao Z., et al. Profiling of REST-dependent microRNAs reveals dynamic modes of expression. Front. Neurosci. 2012, 6:67.
85. Cohen T.J., et al. TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol. Med. 2011, 17:659-667.
86. Kawahara Y., Mieda-Sato A. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:3347-3352.
87. Lastres-Becker I., et al. Spinocerebellar ataxia 2 (SCA2). Cerebellum 2008, 7:115-124.
88. Bonini N.M., Gitler A.D. Model organisms reveal insight into human neurodegenerative disease: ataxin-2 intermediate-length polyglutamine expansions are a risk factor for ALS. J. Mol. Neurosci. 2011, 45:676-683.
89. McCann C., et al. The Ataxin-2 protein is required for microRNA function and synapse-specific long-term olfactory habituation. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:E655-E662.
90. de Lencastre A., et al. MicroRNAs both promote and antagonize longevity in C. elegans. Curr. Biol. 2010, 20:2159-2168.
91. Miska E.A., et al. Most Caenorhabditis elegans microRNAs are individually not essential for development or viability. PLoS Genet. 2007, 3:e215.
92. Alvarez-Saavedra E., Horvitz H.R. Many families of C. elegans microRNAs are not essential for development or viability. Curr. Biol. 2010, 20:367-373.
93. Bartel D.P., Chen C.Z. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet. 2004, 5:396-400.
94. Kato M., Slack F.J. Ageing and the small, non-coding RNA world. Ageing Res. Rev. 2012, 10.1016/j.arr.2012.03.012.
95. Ebert M.S., Sharp P.A. Roles for microRNAs in conferring robustness to biological processes. Cell 2012, 149:515-524.
96. Brenner J.L., et al. Loss of individual microRNAs causes mutant phenotypes in sensitized genetic backgrounds in C. elegans. Curr. Biol. 2010, 20:1321-1325.
97. Liu N., et al. The exoribonuclease Nibbler controls 3' end processing of microRNAs in Drosophila. Curr. Biol. 2011, 21:1888-1893.
98. Han B.W., et al. The 3'-to-5' exoribonuclease Nibbler shapes the 3' ends of microRNAs bound to Drosophila Argonaute1. Curr. Biol. 2011, 21:1878-1887.
99. Pincus Z., et al. MicroRNA predictors of longevity in Caenorhabditis elegans. PLoS Genet. 2011, 7:e1002306.
100. Miyazaki Y., et al. Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2. Nat. Med. 2012, 18:1136-1141.